Current liabilities increased 22.6%
Current liabilities changed +22.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$8.1M→$9.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CLPT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 20.8%
Cash & equivalents changed +20.8% from the comparable as-filed period.
$38.2M→$46.2M3 prior comparisons
SBC / revenue moved 725 bp lower
SBC / revenue changed -725 basis points from the comparable as-filed period.
22.82%→15.57%3 prior comparisons
R&D / revenue moved 568 bp lower
R&D / revenue changed -568 basis points from the comparable as-filed period.
38.96%→33.28%3 prior comparisons
Receivables / revenue moved 2125 bp higher
Receivables / revenue changed +2125 basis points from the comparable as-filed period.
45.14%→66.39%2 prior comparisons
Research & development increased 16.4%
Research & development changed +16.4% from the comparable as-filed period.
$3.5M→$4.0M3 prior comparisons
Free-cash-flow margin moved 13013 bp lower
Free-cash-flow margin changed -13013 basis points from the comparable as-filed period.
-37.47%→-167.59%3 prior comparisons
Operating cash-flow margin moved 13124 bp lower
Operating cash-flow margin changed -13124 basis points from the comparable as-filed period.
-35.22%→-166.46%3 prior comparisons
Debt / assets moved 328 bp lower
Debt / assets changed -328 basis points from the comparable as-filed period.
48.38%→45.10%1 prior comparisons
Debt / revenue moved 9147 bp higher
Debt / revenue changed +9147 basis points from the comparable as-filed period.
329.57%→421.04%0 prior comparisons
Cash / debt moved 4004 bp lower
Cash / debt changed -4004 basis points from the comparable as-filed period.
130.88%→90.84%0 prior comparisons
Capital expenditure decreased 31.2%
Capital expenditure changed -31.2% from the comparable as-filed period.
$199,000→$137,0003 prior comparisons
Stock-based compensation decreased 7.0%
Stock-based compensation changed -7.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$2.0M→$1.9M3 prior comparisons
Capex / revenue moved 111 bp lower
Capex / revenue changed -111 basis points from the comparable as-filed period.
2.25%→1.13%3 prior comparisons
Net debt changed across a sign change
Net debt changed +151.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$9.0M→$4.7M0 prior comparisons
Selling, general & administrative increased 7.1%
Selling, general & administrative changed +7.1% from the comparable as-filed period.
$3.6M→$3.8M3 prior comparisons
Current ratio increased 6.1%
Current ratio changed +6.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
6.37→6.764 prior comparisons
Gross margin moved 138 bp higher
Gross margin changed +138 basis points from the comparable as-filed period.
60.29%→61.67%3 prior comparisons
Research & development increased 21.0%
Research & development changed +21.0% from the comparable as-filed period.
$3.8M→$4.6M3 prior comparisons
SBC / revenue moved 375 bp lower
SBC / revenue changed -375 basis points from the comparable as-filed period.
24.62%→20.87%3 prior comparisons
Current ratio decreased 35.0%
Current ratio changed -35.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
7.3→4.744 prior comparisons
Shares outstanding increased 7.3%
Shares outstanding changed +7.3% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
28,427,417→30,504,2278 prior comparisons
Gross profit increased 20.8%
Gross profit changed +20.8% from the comparable as-filed period.
$5.6M→$6.7M3 prior comparisons
Working capital decreased 17.1%
Working capital changed -17.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$46.6M→$38.6M4 prior comparisons
Receivables / revenue moved 3093 bp higher
Receivables / revenue changed +3093 basis points from the comparable as-filed period.
46.23%→77.16%2 prior comparisons
Operating cash-flow margin moved 3678 bp lower
Operating cash-flow margin changed -3678 basis points from the comparable as-filed period.
-27.69%→-64.48%3 prior comparisons
Free-cash-flow margin moved 3776 bp lower
Free-cash-flow margin changed -3776 basis points from the comparable as-filed period.
-28.68%→-66.44%3 prior comparisons
Debt / revenue moved 14867 bp higher
Debt / revenue changed +14867 basis points from the comparable as-filed period.
313.02%→461.69%0 prior comparisons
Cash / debt moved 8556 bp lower
Cash / debt changed -8556 basis points from the comparable as-filed period.
144.01%→58.45%0 prior comparisons
Debt / assets moved 1203 bp higher
Debt / assets changed +1203 basis points from the comparable as-filed period.
45.88%→57.91%0 prior comparisons
Current assets decreased 9.4%
Current assets changed -9.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$54.0M→$48.9M4 prior comparisons
Cost of revenue increased 14.0%
Cost of revenue changed +14.0% from the comparable as-filed period.
$3.7M→$4.2M3 prior comparisons
Capex / revenue moved 98 bp higher
Capex / revenue changed +98 basis points from the comparable as-filed period.
0.99%→1.97%3 prior comparisons
R&D / revenue moved 102 bp higher
R&D / revenue changed +102 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
41.55%→42.57%3 prior comparisons
Net debt changed across a sign change
Net debt changed +264.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$12.7M→$20.9M0 prior comparisons
Stock-based compensation increased 0.1%
Stock-based compensation changed +0.1% from the comparable as-filed period.
$2.3M→$2.3M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.